Increased susceptibility of cells treated with interferon to the toxicity of polyriboinosinic-polyribocytidylic acid.
D000818:Animals; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D003588:Cytopathogenic Effect, Viral; D003851:Deoxyribonucleases / Q000494:pharmacology; D004355:Drug Stability; D004622:Embryo, Mammalian / Q000187:drug effects*; D005347:Fibroblasts / Q000187:drug effects* / Q000378:metabolism; D006358:Hot Temperature; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007372:Interferons / Q000096:biosynthesis / Q000494:pharmacology* / Q000528:radiation effects; D007739:L Cells / Q000187:drug effects*; D051379:Mice; D009522:Newcastle disease virus; D011070:Poly I-C / Q000494:pharmacology; D011119:Polynucleotides / Q000494:pharmacology*; D011830:Radiation Effects; D012260:Ribonucleases / Q000494:pharmacology; D014357:Trypsin / Q000494:pharmacology; D014461:Ultracentrifugation; D014466:Ultraviolet Rays
D011119:Polynucleotides; D007372:Interferons; D003851:Deoxyribonucleases; D012260:Ribonucleases; D014357:Trypsin; D011070:Poly I-C